IQVIA’s August 2024 white paper summarizes a roundtable on advancing health equity in the life sciences. Despite progress—like the formation of DEI teams and community partnerships—health equity efforts remain fragmented and hard to measure. Leaders highlighted the need for embedding equity into brand strategy, using data to build business cases, and prioritizing underserved populations. Challenges include defining metrics, gaining internal buy-in, and showing ROI. Opportunities lie in setting industry standards, sharing data, and driving multi-stakeholder collaboration. A global, end-to-end, business-oriented approach is essential for sustainable impact.

Join for free to read